Could CAR t-cells tame autoimmune disease? new trial launches.
NCT ID NCT06680037
First seen Oct 31, 2025 · Last updated May 20, 2026 · Updated 28 times
Summary
This early-phase study tests a new treatment called azercabtagene zapreleucel (azer-cel) for people with B-cell mediated autoimmune disorders like multiple sclerosis. About 100 adults will receive this cell therapy to find the safest dose and see if it can control disease activity. The goal is to manage the condition, not cure it, as ongoing treatment may still be needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL MEDIATED AUTOIMMUNE DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
TG Therapeutics Investigational Trial Site
RECRUITINGLa Jolla, California, 92093, United States
-
TG Therapeutics Investigational Trial Site
RECRUITINGAnn Arbor, Michigan, 48019, United States
-
TG Therapeutics Investigational Trial Site
RECRUITINGOmaha, Nebraska, 68198, United States
-
TG Therapeutics Investigational Trial Site
RECRUITINGNew York, New York, 10025, United States
-
TG Therapeutics Investigational Trial Site
RECRUITINGRochester, New York, 14642, United States
-
TG Therapeutics Investigational Trial Site
RECRUITINGCleveland, Ohio, 44195, United States
-
TG Therapeutics Investigational Trial Site
RECRUITINGColumbus, Ohio, 43210, United States
-
TG Therapeutics Investigational Trial Site
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Conditions
Explore the condition pages connected to this study.